This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: The University of Western Ontario. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: Yan Li - Innovator in HIV Vaccine Development
Introduction
Yan Li is a prominent inventor based in London, Canada, known for his significant contributions to the field of HIV vaccine research. With a total of two patents to his name, he has made strides in developing innovative solutions to combat HIV.
Latest Patents
Yan Li's latest patents include groundbreaking work on recombinant lentivirus encoding modified GP 120 signal sequences. This patent focuses on novel HIV vaccines that comprise an avirulent and non-cytolytic recombinant HIV. Additionally, he has developed a unique HIV vaccine that features an avirulent and non-cytolytic recombinant HIV, wherein the NSS of the virus' envelope glycoprotein is replaced with a non-cytolytic signal sequence, and the nef gene of the virus is deleted, rendering the virus avirulent.
Career Highlights
Yan Li is affiliated with the University of Western Ontario, where he continues to advance his research in the field of virology and vaccine development. His work has garnered attention for its potential to provide effective solutions against HIV.
Collaborations
Yan Li collaborates with Chil-Yong Kang, a fellow researcher who contributes to the innovative projects at the University of Western Ontario.
Conclusion
Yan Li's contributions to HIV vaccine development highlight his role as a key innovator in the field. His patents reflect a commitment to advancing medical science and improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile